I had some luck with an older pick from this board with FRPT, and am wondering what everyone currently thinks of CRDC. I was in and out of this one a few months back, and was fortunate to make a little money on it in the short term. I remember this discussed fairly often awhile back, and am wondering if anyone has been following it recently and what there thoughts were.
One thing I noticed was, while not a lot of money, there was some insider buying in the last month. I don't want to put too much confidence in that, but it usually is a decent sign.
I'm thinking of taking a shot on this in the $3.50 range
To remove first post, remove entire topic.
I had some luck with an older pick from this board with FRPT, and am wondering what everyone currently thinks of CRDC. I was in and out of this one a few months back, and was fortunate to make a little money on it in the short term. I remember this discussed fairly often awhile back, and am wondering if anyone has been following it recently and what there thoughts were.
One thing I noticed was, while not a lot of money, there was some insider buying in the last month. I don't want to put too much confidence in that, but it usually is a decent sign.
I'm thinking of taking a shot on this in the $3.50 range
Gonna get back into the stock early next year, the stock is just in the doldrums.
Its a smaller float stock with very little following, very little debt and FDA approval, I wouldnt be shocked if this is a double plus this year. I considered it to be my play this year but went with Delta instead.
I love that play.
Gonna get back into the stock early next year, the stock is just in the doldrums.
Its a smaller float stock with very little following, very little debt and FDA approval, I wouldnt be shocked if this is a double plus this year. I considered it to be my play this year but went with Delta instead.
I remember you liked that stock in the past, and while I did some of my own research, I wanted to see if there was something I might have missed that someone who followed it a little closer may have caught.
Obviously a lot of stocks have been hit pretty hard, and I don't quite have the end of the world mentality of some of the others on this board, so I am sifting through and trying to find some bargains with high upside. I see this as a pretty good candidate.
Picked up some shares at $3.48. It it gets a little upward momentum, I might add a few more shares sometime in the next few months.
WSC
I remember you liked that stock in the past, and while I did some of my own research, I wanted to see if there was something I might have missed that someone who followed it a little closer may have caught.
Obviously a lot of stocks have been hit pretty hard, and I don't quite have the end of the world mentality of some of the others on this board, so I am sifting through and trying to find some bargains with high upside. I see this as a pretty good candidate.
Picked up some shares at $3.48. It it gets a little upward momentum, I might add a few more shares sometime in the next few months.
Earnings are tomorrow and they took it down a TON on no news or any good reason.
The move today was nice, but this is a 20 plus buck stock when the product grabs market share..anything under 6 bucks is a steal longer term..but they have to execute.
Earnings are tomorrow and they took it down a TON on no news or any good reason.
The move today was nice, but this is a 20 plus buck stock when the product grabs market share..anything under 6 bucks is a steal longer term..but they have to execute.
Looked reasonable to me..revenue numbers stronger Q over Q, R&D numbers were higher as they try to train and ramp up.
The company still is not to critical mass or the PPS would be much higher..early innings still and since surgeons have to be TRAINED on this, it isnt a POZN style drug where you market it via commercials and physicians write scripts, it will take LONGER to get to that critical mass, but when it does the repeat business should stay constant for a VERY long time.
Depeche,
Looked reasonable to me..revenue numbers stronger Q over Q, R&D numbers were higher as they try to train and ramp up.
The company still is not to critical mass or the PPS would be much higher..early innings still and since surgeons have to be TRAINED on this, it isnt a POZN style drug where you market it via commercials and physicians write scripts, it will take LONGER to get to that critical mass, but when it does the repeat business should stay constant for a VERY long time.
CRDC up 40% on peer-reviewed publication validating its procedure.
wall, what do you think?
I sold some shares that I bought at 1.20 for 2.60 today, holding half of my position though.
This publication was about another application they have, not the core application..it was for their medical stapling tool.
This could take a while but I dont see how given the multiple products that this isnt a 10-15 buck stock, or why ISRG does not snap them up down here, their product line works with the ISRG Robot.
Quote Originally Posted by depeche2:
Bump
CRDC up 40% on peer-reviewed publication validating its procedure.
wall, what do you think?
I sold some shares that I bought at 1.20 for 2.60 today, holding half of my position though.
This publication was about another application they have, not the core application..it was for their medical stapling tool.
This could take a while but I dont see how given the multiple products that this isnt a 10-15 buck stock, or why ISRG does not snap them up down here, their product line works with the ISRG Robot.
Well Ive been holding her for a very long time, but sometimes it takes a while until the market realizes how great a stock is. I am more often early buying and selling.
Another gem I've been holding for several years is UVE, a florida based casualty insurer who pays out a current 8% yield, but for me with my cost basis I think I am in the 15-16% div yield range.
These few offset my current crappy FAZ holding.
Well Ive been holding her for a very long time, but sometimes it takes a while until the market realizes how great a stock is. I am more often early buying and selling.
Another gem I've been holding for several years is UVE, a florida based casualty insurer who pays out a current 8% yield, but for me with my cost basis I think I am in the 15-16% div yield range.